MARITES PILAPIL: Open Payments
NPI 1952752511 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,890 in 96 payments from 24 companies in 2025. Trend: 2023 $2,318 · 2024 $2,344 · 2025 $1,890
Food & beverage: $1,890
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $558 |
| Neurocrine BioSciences, Inc. | 7 | $268 |
| PFIZER INC. | 6 | $122 |
| ARGENX US, INC. | 3 | $88 |
| Lundbeck LLC | 4 | $84 |
| Biogen, Inc. | 4 | $83 |
| Lilly USA, LLC | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| UCB, Inc. | 2 | $67 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
Products named: UBRELVY, INGREZZA, BOTOX, NURTEC ODT, QULIPTA, VYVGART HYTRULO, REXULTI, KESIMPTA.
Industry payments across NV — which companies pay providers there.
